C07D251/46

CFTR REGULATORS AND METHODS OF USE THEREOF
20200181097 · 2020-06-11 ·

Provided herein are compounds that activate CFTR and methods for treating constipation, dry eye disorders, and other diseases and disorders.

CFTR REGULATORS AND METHODS OF USE THEREOF
20200181097 · 2020-06-11 ·

Provided herein are compounds that activate CFTR and methods for treating constipation, dry eye disorders, and other diseases and disorders.

TRIAZINE-BASED SELF-ASSEMBLING SYSTEM

A Janus G-C base as building block for a triazine based self-assembly of formula (I), a process for the preparation, and its application in developing supramolecular polymers, peptide nucleic acids (PNAs) and smart polymers thereof. A triazine based self-assembly of formula (I):

##STR00001## wherein, R is selected from the group comprising of linear or branched unsubstituted and substituted C1-C7 alkyl, unsubstituted and substituted aryl, unsubstituted and substituted natural amino acids which may be protected, linear or branched unsubstituted and substituted C1-C7 alcohols, or linear or branched unsubstituted and substituted C1-C7 amines.

TRIAZINE-BASED SELF-ASSEMBLING SYSTEM

A Janus G-C base as building block for a triazine based self-assembly of formula (I), a process for the preparation, and its application in developing supramolecular polymers, peptide nucleic acids (PNAs) and smart polymers thereof. A triazine based self-assembly of formula (I):

##STR00001## wherein, R is selected from the group comprising of linear or branched unsubstituted and substituted C1-C7 alkyl, unsubstituted and substituted aryl, unsubstituted and substituted natural amino acids which may be protected, linear or branched unsubstituted and substituted C1-C7 alcohols, or linear or branched unsubstituted and substituted C1-C7 amines.

Macromolecular Antioxidants Based On Dual Type Moiety Per Molecule: Structures, Methods Of Making And Using The Same
20190292454 · 2019-09-26 ·

Disclosed are compounds represented by structural formula

##STR00001## methods of producing compounds represented by structural formula, and their use in inhibiting oxidation in an oxidizable material.

Macromolecular Antioxidants Based On Dual Type Moiety Per Molecule: Structures, Methods Of Making And Using The Same
20190292454 · 2019-09-26 ·

Disclosed are compounds represented by structural formula

##STR00001## methods of producing compounds represented by structural formula, and their use in inhibiting oxidation in an oxidizable material.

Process for Preparing a Triazine-Based Precursor, the Precursor Prepared Thereby, a Method for Producing a Micro-Particulate Complex Using the Precursor, and the Micro-Particulate Complex Produced Thereby

A process for preparing a triazine-based precursor for producing a micro-particulate complex containing a far infrared-emissive silica particle comprises steps of: a) subjecting 2-4-6-trichloro-1,3,5-triazine and a first nucleophilic compound to a displacement reaction in the presence of a first solvent at a first temperature range to form an intermediate; and b) subjecting the intermediate and a second nucleophilic compound to a further displacement reaction in the presence of a second solvent at a second temperature range higher than the first temperature range.

Bleed-out preventing agent, composition for preventing bleed-out including the same, and method of preventing bleed-out
10196367 · 2019-02-05 · ·

Provided are a bleed-out preventing agent and a composition for preventing bleed-out including the same.

Bleed-out preventing agent, composition for preventing bleed-out including the same, and method of preventing bleed-out
10196367 · 2019-02-05 · ·

Provided are a bleed-out preventing agent and a composition for preventing bleed-out including the same.

METHOD FOR THE INDUSTRIAL PRODUCTION OF 2-HALO-4,6-DIALKOXY-1,3,5-TRIAZINES AND THEIR USE IN THE PRESENCE OF AMINES
20180370924 · 2018-12-27 · ·

A method for stabilization of collagen matrices and of condensation of natural and synthetic polymers that uses 2-halo-4, 6-dialkoxy-1, 3, 5-triazines in the presence of one or more amines as activating agents for reactions of crosslinking, condensation, grafting, and curing of collagen matrices, cellulose, modified celluloses, polysaccharides, acid unsaturated polymers, and chiral and non-chiral amines, etc. Forming an integral part of the present invention is also the method for production on an industrial scale of 2-halo-4, 6-dialkoxy-1, 3, 5-triazines.